B+
Bull case
25%
Probability
Target price
$35.00
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
OMDA
Omada HealthANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$28.25
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$17.50
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-04
Recent news sentiment (30D)
+78.0
Positive
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+94.6
Score
AI commentary
News tone is constructive following strong Q2 results, raised guidance, and the announced Investor Day [#SEC-8K-2026-08-06]. Social, options, short-interest, employee-rating, and analyst-revision data are unavailable; missing data is not treated as positive evidence. Insider activity provides a modest counter-signal [#SEC-FORM4-2026-09-03].
RankAlpha Sentiment Codex - 2026-09-04
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-06eventQ2 2026 earnings and raised FY26 outlookHigh impact
Already reported: revenue grew 43% year over year to $88 million, gross margin reached 73%, adjusted EBITDA was $11 million, and FY26 revenue guidance was raised to $334-$340 million from $322-$330 million [#SEC-8K-2026-08-06].
2026-09-10eventInvestor Day on September 10, 2026High impact
Omada plans to present its vision, strategy, and long-term growth plans. The event could clarify durability of growth, margin potential, and execution plans, but expectations may already reflect the strong Q2 print [#SEC-8K-2026-08-06].
2026-09-30catalystRecent insider sellingMedium impact
Founder Sean Duffy reported open-market sales on September 1, while additional officer dispositions were reported for tax withholding. This is a secondary caution signal and does not establish operating weakness [#SEC-FORM4-2026-09-03].
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-04 • Updated nightlySource: Internal modelMethodology